Projected impacts for Asian Medicare enrollees
- Collection:
- Health Policy and Services Research
- Alternate Title(s):
- Projected impacts for Asian Medicare enrollees
- Series Title(s):
- Fact sheet (United States. Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation. Office of Health Policy) and Inflation Reduction Act research series
- Contributor(s):
- United States. Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation. Office of Health Policy, issuing body.
- Publication:
- Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, 2023
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Asian Drug Costs -- legislation & jurisprudence Forecasting Medicare Part D -- economics Medicare Part D -- legislation & jurisprudence United States United States.
- Genre(s):
- Technical Report
- Abstract:
- The Inflation Reduction Act (IRA) is helping people with Medicare, including the 2.1 million Medicare Part D enrollees who identify as Asian. Our review shows that in 2020, about 31,000 Asian enrollees would have benefited from the IRA’s $35 insulin cap and in 2021, about 159,000 enrollees would not have had any out-of-pocket costs for recommended Part D covered adult vaccines. Under the IRA’s Part D redesign, about 33,800 Asian Medicare enrollees who do not receive financial assistance are projected to save $1,000 or more in 2025. Additional benefits are expected for this population from other IRA drug-related provisions.
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (9 pages)).
- NLM Unique ID:
- 9918751183906676 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/9918751183906676